6-K - Bon Natural Life Ltd (0001816815) (Filer)

6-K - Bon Natural Life Ltd (0001816815) (Filer)

6-K - Bon Natural Life Ltd (0001816815) (Filer)

6-K - Bon Natural Life Ltd (0001816815) (Filer)

F-3/A - Bon Natural Life Ltd (0001816815) (Filer)

F-3 - Bon Natural Life Ltd (0001816815) (Filer)

6-K - Bon Natural Life Ltd (0001816815) (Filer)

6-K - Bon Natural Life Ltd (0001816815) (Filer)

6-K - Bon Natural Life Ltd (0001816815) (Filer)

6-K - Bon Natural Life Ltd (0001816815) (Filer)

XI'AN, China, Feb. 19, 2026 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, today announced the successful development of a premium anti-aging facial mask incorporating apple polyphenols as its core active ingredient and integrated with AI-enabled flexible bio-electronic technology. Leveraging advanced transdermal delivery systems, this product integrates plant-derived active ingredients with intelligent flexible electronics, creating a next-generation skin care solution designed to be non-invasive, painless, and suitable for at-home use. Serving as the core na

XI'AN, China, Feb. 17, 2026 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, today announced the establishment of the BON & Pilot Joint Laboratory for Natural Ingredients and Bio-Manufacturing (the "Joint Laboratory"). The Joint Laboratory was inaugurated on December 18, 2025 through a collaboration between the Company's domestic operating subsidiary, Xi'an App-Chem Bio-Tech Co., Ltd., and Shaanxi Chang'an Pilot Life Science Industry Innovation Center Co., Ltd. ("Chang'an Pilot"). The Joint Laboratory will focus on the research and development of bio-manufactured natural activ

XI'AN, China, Dec. 10, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced the launch of a new health-focused kombucha-inspired product and a strategic collaboration with Shaanxi Qingshengyuan Health Industry Co., Ltd. ("Qingshengyuan"), a leading distributor of functional health products in China focusing on digestive and metabolic wellness. The two parties entered into a non-exclusive strategic sales agreement. The term of the agreement is 24 months with a total contract value of $12 million. Pursuant to the agreement, Qingshengyuan will sell and di

XI'AN, China, Nov. 25, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan") a prominent health products distributor in China. The term of the agreement is 36 months with a total contract value of US$26 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute BON's second-generation tea pigment-based digestive health products in Greater China. Tea pigments, a key bioactive complex derived from tea, possess a strong scientific profile

XI'AN, China, Sept. 9, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced it has entered into a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan") a prominent health products distributor in China. The term of the agreement is 24 months with a total contract value of US$18 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute BON's innovative second-generation Apple Series health products across Greater China, tapping into significant market potential in the weight management and m

XI'AN, China, Sept. 2, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a groundbreaking identification of a class of natural polyphenolic compounds from a tea-derived product via its AI-Powered new drug research and development (R&D) platform. Preliminary tests demonstrate that these compounds exhibit significant activity in weight management, with key efficacy indicators outperforming current mainstream weight-managing drugs, injecting new momentum into global R&D of weight-managing drugs. With a worsening global obesity crisis, the weight-manag

XI'AN, China, Aug. 5, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced reciept of compliance notification from the Nasdaq Stock Market LLC. As previously reported on a Form 6-K filed with the U.S. Securities and Exchange Commission on July 11, 2025, Bon Natural Life Limited ( "the Company") received notification from the Nasdaq Hearings Panel (the "Panel") that the Company had regained compliance with Listing Rule 5550(a)(2) (the "Bid Price Rule"). The Panel also advised the Company that it will be subject to a one-year Discretionary Panel M

XI'AN, China, July 30, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced the official launch of its AI-driven drug research and development (R&D) business. Leveraging its extensive library of natural compounds - many derived from Traditional Chinese Medicine (TCM) - the Company will apply artificial intelligence algorithms to identify high potential lead compounds, marking a significant evolution in its pharmaceutical strategy. A lead compound is a molecule with specific biological activity and a chemical structure that serves as a foundation

XI'AN, China, July 21, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural health and personal care industries, today announced it has entered into a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan"). The term of the agreement is 36 months with a total contract value of US$22 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute Bon's natural weight loss product line across China and Southeast Asia. What sets BON apart is not only the science behind its formulation but also its exceptional user compliance. By eli

XI'AN, China, July 14, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced that it has regained compliance with Nasdaq's continued listing requirements. On July 2, 2025, the Company received formal notice from the Nasdaq Hearings Panel confirming that BON has successfully met the Minimum Bid Price Requirement under Nasdaq Listing Rule 5550(a)(2). As a result, the Panel has granted the Company's request to maintain its listing on the Nasdaq Capital Market. BON submitted its plan of compliance to Nasdaq on May 16, 2025, and subsequently presented its c

XIAN, China, April 25, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, is pleased to announce the appointment of Mr. Wallace Lee as Chief Financial Officer (CFO), effective April 17, 2023. Mr. Lee succeeds Zhenchao Li, who stepped down from the role of CFO after a 4-year career with the Company, effective April 17, 2023. "We welcome Wallace Lee into BON's executive leadership team." Commented Richard Hu, "Wallace brings exceptional financial, strategic, and operational experience both from multiple industry sectors and experience as a public c

XIAN, China, June 30, 2022 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced the appointment of Jeffrey Guzy, as a new independent Director to its Board of Directors and as Chair of the Audit Committee, both effective June 28, 2022. Effective June 27, 2022, Mr. Christopher Constable resigned as a director of the Company for personal reasons and stepped down as a member and chairman of the audit committee of the Board. The resignation of Mr. Constable did not result from any dispute or disagreement with the Company or the Board on any matter

Earnings to be released before market opens on Friday, February 10, 2023 XIAN, China, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, will issue its FY2022 earnings release for the fiscal year ended September 30, 2021 before the market open on Friday, February 10, 2023. BON will also host an investor conference call and webcast on the same date, beginning at 9:00 a.m. EST. Management on the call will include CEO Mr. Richard (Yongwei) Hu, CFO Mr. Zhenchao Li, COO Ms. Yingchun Xue and CMO Wenjuan Chen. A replay of the call will also be

Earnings to be released before market opens on Monday, August 1, 2022XIAN, China, July 28, 2022 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, will issue its half-year earnings release for the reporting period ended March 31, 2022 before the market open on Monday, August 1, 2022. BON will also host an investor conference call and webcast on the same date, beginning at 9:00 a.m. EST. Management on the call will include CEO Mr. Richard (Yongwei) Hu, CFO Mr. Zhenchao Li, COO Ms. Yingchun Xue and CMO Wenjuan Chen. A replay of the call will also be archived o

Earnings to be released before market opens on Monday, January 31, 2022 XI'AN, China, Jan. 28, 2022 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, will issue its FY2021 earnings release for the fiscal year ended September 30, 2021 before the market open on Monday, January 31, 2022. In observation of Chinese New Year, BON will host an investor conference call and webcast on February 3 beginning at 9:00 a.m. EST. Management on the call will include CEO Mr. Richard (Yongwei) Hu, CFO Mr. Zhenchao Li, CMO Ms. Wenjuan Chen and COO Ms. Yingchun Xue. A replay

Earnings to be released before market opens on Tuesday, August 17, 2021 XIAN, China, Aug. 12, 2021 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, will issue its half-year earnings release for the reporting period ended March 31, 2021 before the market open on Tuesday, August 17, 2021. BON will also host an investor conference call and webcast on the same day beginning at 8:30 a.m. EST. Management on the call will include CEO Mr. Richard (Yongwei) Hu, CFO Mr. Zhenchao Li and COO Ms. Yingchun Xue. A replay of the call will also be archived on the Company